Redefining clinical trials: Adopting AI for speed, volume and diversity
IBM Big Data Hub
MAY 6, 2024
Industry analysts report that dropout rates in phase 3 clinical trials can sometimes reach 20% to 30%. Patient pool expansion hurdles : Despite efforts to broaden participant inclusion, clinical trials still face hurdles in identifying and engaging new patient demographics, especially underrepresented groups.
Let's personalize your content